BMY value play breakoutBMY is one of my more recent value additions to the stock portfolio, I was able to snag this around the lows and the stock is breaking out today. Value will have its day and a few stocks are already moving. Once you obtain a certain net worth, safety becomes more important than just flat out growth and performance.
-Short-term 55$ target remains
-60.8$ is my target for the year
-15-20% performance on a value play is substantial, and this does not include the dividend which will become attractive as yields being to drop
BMY trade ideas
BMY pushing into a sorta-kinda-almost gap. BullishI like NYSE:BMY here. I already own shares, but am adding a call spread.
Obviously, I am chasing short-term a bit, which is not generally a good idea. In this case I am willing to take the risk because of the overhead gap in volume (it's not a true gap, of course), and the fact that the stock seems ready to break its long-term down trend.
Fundamentally, I think the strength is supported by good earnings, low P/E, a rich dividend, and recent successes in drug trials. The reason for the longer-term weakness is the threat of blockbuster drugs losing their protection from generics, and increased leverage, due to the company buying out smaller biotechs to improve its drug pipeline.
I added a March 24, 54/56 call spread, currently priced at 60¢.
$BMY PA interacting at Monthly 200maIf the monthly 200 holds as macro support, we could see a retrace bounce back to meet the monthly 12ema which is descending from 56.75.
If there's an entry here for me, it won't be before a confirmed hourly trend change.
Monthly RSI is attempting a bounce just ahead of fully oversold conditions.
BMY about to pushBMY had a great earnings report on this undervalued stock, I did cut PFE shortly after entering it a few weeks ago to all-in on BMY as my pharmaceutical exposure. I believe this will be a great value play all year. My short-term target is still 55$, but 60$ is definitely in the cards as the price was way below fundamentals.
BMY - Patience is a Virtue 🧘Hello TradingView Family / Fellow Traders,
On Monthly: Left Chart
BMY has been hovering inside a range between the 50 support and 70 resistance.
Currently BMY is approaching the lower bound of the range, so we will be looking for buy setups on lower timeframes.
On Daily: Right Chart
📈 For the bulls to take over, we need a momentum candle close above the last major high in gray at 54.
📉 Meanwhile, BMY would be bearish and can still trade lower to dive inside the 44-50 support zone before trading higher.
📚 Always follow your trading plan regarding entry, risk management, and trade management.
Good luck!
All Strategies Are Good; If Managed Properly!
~Richard Nasr
BMY adding a value playI believe 2024 will be a year of value stocks. With such great tech performance last year it is getting harder to find opportunity in the market. I tend to be very comfortable buying into what people hate, I added a large amount of PFE recently hoping for it to play out how Verizon did for me last year. I am consolidating some risk from my stock portfolio into large cap value since I have so much risk with crypto already.
The weekly supertrend for BMY has not yet flipped bullish, but is is bullish on the daily. Now is buy time in Jan in my opinion as the monthly is contracting as well. The RSI swept the lows, and has a nice reset My first target is marked by the dashed green but I expect the .382 fib or 61$ as well.
BMY long positionHello Traders!
Let's take a look at BMY stocks on a daily timeframe. BMY has been on a downtrend for almost a year now. We expect the price to continue the downtrend and then test the support at the swing low from the end of 2021. We then take long position, expecting the price to break the pattern upwards.
What's your opinion? Let us know in the comments.
BMY to stall at previous support?Bristol-Myers Squibb Co - 30d expiry - We look to Sell at 62.98 (stop at 65.08)
There is no clear indication that the downward move is coming to an end.
Intraday rallies continue to attract sellers and there is no clear indication that this sequence for trading is coming to an end.
We look for a temporary move higher.
Previous support at 63 now becomes resistance.
This stock has seen poor sales growth.
Our profit targets will be 58.08 and 57.08
Resistance: 60.89 / 62.50 / 63.41
Support: 59.45 / 57.50 / 55.00
Please be advised that the in formation presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group
Selling BMY at previous support.Bristol-Myers Squibb Co - 30d expiry - We look to Sell at 62.98 (stop at 65.08)
Daily signals are bearish.
Intraday rallies continue to attract sellers and there is no clear indication that this sequence for trading is coming to an end.
We look for a temporary move higher.
Previous support at 63 now becomes resistance.
50 1 day EMA is at 63.70.
Our profit targets will be 58.08 and 57.08
Resistance: 61.75 / 63.00 / 65.38
Support: 60.05 / 57.50 / 55.00
Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Everest Fortune Group’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Everest Fortune Group.
BMY to break through double top?Bristol-Myers Squibb Co - 30d expiry - We look to Buy a break of 71.21 (stop at 68.61)
Prices have reacted from 65.28.
65.28 has been pivotal.
Posted a Double Top formation.
71.07 has been pivotal.
A break of the recent high at 71.07 should result in a further move higher.
This stock has seen good sales growth.
Our profit targets will be 77.71 and 78.71
Resistance: 69.00 / 70.00 / 71.07
Support: 67.80 / 66.00 / 65.30
Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.